[Funding alert] Cancer Therapy Platform Bicara Secures $165 Mn Series C FundingInsightBy Viestories14 Dec 2023 12:04 ISTBicara Therapeutics, a clinical-stage biotechnology firm, has announced the completion of an oversubscribed $165 million Series C fundraising. The company develops dual-action biologics to elicit a powerful and lasting immune response.Read More
![[Funding alert] Cancer Therapy Platform Bicara Secures $165 Mn Series C Funding](https://img-cdn.publive.online/fit-in/580x348/filters:format(webp)/viestories/media/post_attachments/wp-content/uploads/2023/12/Cancer-Therapy-Platform-Bicara-Secures-165-Mn-Series-C-Funding.webp)